The Impact of Posttransplant Lymphoproliferative Disease in High-risk Kidney Transplant Recipients: Benefits of Prevention

Background. Posttransplant lymphoproliferative disease (PTLD) is increased in kidney transplant recipients who are Epstein-Barr virus (EBV) nonimmune (R–), particularly if the donor has prior EBV immunity (D+). PTLD is associated with very high mortality. The purpose of this study was to quantify th...

Full description

Saved in:
Bibliographic Details
Main Authors: Bryce A. Kiberd, MD, Christopher J.A. Daley, BscPharm, ACPR, PharmD
Format: Article
Language:English
Published: Wolters Kluwer 2025-05-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001792
Tags: Add Tag
No Tags, Be the first to tag this record!